A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine
Clinical trial NCT05694728 · COMPLETED
Trial details
- NCT number
- NCT05694728
- Sponsor
- Beijing Health Guard Biotechnology, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-23
- Primary completion
- 2020-12-11
- Enrollment
- 780
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.